Bellus Health Inc.
Acted for Bellus Health Inc. in the filing of a base shelf prospectus.
Sébastien Roy
Partner
Bar Admissions
- Québec, 2003
Sébastien advises on significant public and private mergers and acquisitions.
He also represents issuers and underwriters in public offerings and private placements of equity and debt securities, in both Canada and the U.S. He works extensively with REITS, financial institutions and financial technology and life science companies. Sébastien has also represented investors with their investments in Canadian mining companies. Clients regularly turn to him for assistance with securities regulation compliance and corporate governance advice.
Sébastien is a long-standing contributor to Montréal’s vital arts scene, both as a fundraiser and as a volunteer. He is chairman of the board of Fondation de la Maison Théâtre.
Sébastien Roy
Partner
Sébastien advises on significant public and private mergers and acquisitions.
He also represents issuers and underwriters in public offerings and private placements of equity and debt securities, in both Canada and the U.S. He works extensively with REITS, financial institutions and financial technology and life science companies. Sébastien has also represented investors with their investments in Canadian mining companies. Clients regularly turn to him for assistance with securities regulation compliance and corporate governance advice.
Sébastien is a long-standing contributor to Montréal’s vital arts scene, both as a fundraiser and as a volunteer. He is chairman of the board of Fondation de la Maison Théâtre.
BELLUS Health Inc.
Acted for BELLUS Health Inc. in its $35-million overnight marketed offering of common shares to support the development of its lead drug candidate BLU-5937 for chronic cough.
Caisse de dépôt et placement du Québec
Acted for Caisse de dépôt et placement du Québec in the purchase of a block of shares of Stella-Jones Inc. from Stella Jones International S.A. for approximately $182 million pursuant to a private placement.
Rogers Sugar Inc.
Acted for Rogers Sugar Inc. in connection with the issuance, on a bought deal basis, of $97,750,000 aggregate principal amount of convertible unsecured subordinated debentures.
BELLUS Health Inc.
Acted for BELLUS Health Inc. in its $20-million overnight marketed offering of common shares.
BNP Paribas S.A.
Acted for BNP Paribas S.A. in connection with an investment by the Caisse de dépôt et placement du Québec in Innocap Investment Management Inc.
BMO Nesbitt Burns Inc.
Acted for a syndicate of agents co-led by BMO Nesbitt Burns Inc., National Bank Financial Inc. and CIBC World Markets Inc. on the following private placement by Metro Inc. to partially finance its acquisition of The Jean-Coutu Group (PJC) Inc.: $1.2 billion aggregate principal amount of 2.68% Series F senior unsecured notes due December 5, 2022; 3.39% Series G senior unsecured notes due December 6, 2027; and 4.27% Series H senior unsecured notes due December 4, 2047.
Rogers Sugar Inc.
Acted for Rogers Sugar Inc. in the $40-million acquisition by its subsidiary L.B. Maple Treat Corporation of Decacer, a major bottler and distributor of branded and private label maple syrup and maple sugar, based in Dégelis, Québec.
BMO Nesbitt Burns Inc.
Acted for the Bank of Montreal, Canadian Imperial Bank of Commerce and National Bank of Canada, which together have committed bank facilities of $3.4 billion to finance the cash portion of Metro Inc.'s $4.5 billion acquisition of The Jean Coutu Group Inc.
Rogers Sugar Inc.
Acted for Rogers Sugar Inc. in connection with the $160.3 million acquisition of L.B. Maple Treat Corporation; and the issuance of $69.2 million subscription receipts on a bought deal basis, and $57.5 million of extendible convertible unsecured subordinated debentures.
Guide
2018 Canadian Capital Markets Report: Looking Back, Looking Ahead
May 03, 2018 - While global markets remained volatile in 2017, Canadian capital markets saw a resurgence of IPOs and the emergence of new industries such as cannabis and blockchain. Canadian regulators also kept busy in 2017 responding to shareholder complaints and investigating ways to reduce the regulatory...
In the News
Sébastien Roy Interviewed by Lexpert about Dealmaking in the Maple Syrup Business
Feb. 13, 2018 - Davies partner Sébastien Roy was recently interviewed for a Lexpert Magazine article about transactions in the maple syrup industry, including Rogers Sugar’s (RSI’s) $160.3-million acquisition of L.B. Maple Treat (LBMT) last August.Sébastien believes it was the right time for RSI and its...
Guide
Canadian Capital Markets Report 2017: Looking Back, Looking Ahead
Mar. 31, 2017 - Canadian capital markets in 2016 were turbulent and unpredictable, to say the least. Factors that contributed to shaky investor confidence included the unprecedented British vote to exit the European Union, the hard fought and (to some) surprising result of the U.S. presidential election, a...
Guide
Sept. 21, 2015 - The multijurisdictional disclosure system (MJDS) permits eligible Canadian issuers to publicly offer securities in the United States by using a prospectus that is prepared principally in accordance with Canadian disclosure requirements. The MJDS also enables these issuers to substantially...
Bulletin
Let’s Meet Halfway: CSA Adopts Amendments to Streamline Venture Issuers’ Disclosure
Apr. 15, 2015 - On April 9, 2015, the Canadian Securities Administrators (CSA) announced the adoption of amendments to continuous disclosure, governance and prospectus disclosure requirements (the Amendments).1 Most of the Amendments streamline the disclosure requirements for venture issuers and aim to reduce some...
Bulletin
Women on Boards and in Senior Management: Final Disclosure Rules Released
Oct. 15, 2014 - On October 15, 2014, the securities regulatory authorities of Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Nunavut, Ontario, Québec and Saskatchewan (the participating jurisdictions) announced the final amendments to National Instrument 58-101...
Bulletin
CSA Propose Amendments to Streamline Venture Issuers Disclosure
June 03, 2014 - On May 22, 2014, the Canadian Securities Administrators (the CSA) published for comment proposed amendments to National Instrument 51-102 Continuous Disclosure Obligations (referred to in Québec as Regulation 51-102 respecting Continuous Disclosure Obligations) (collectively, NI...
IFLR1000: The Guide to the World’s Leading Financial Law Firms—Capital Markets: Debt; Capital Markets: Equity
The Canadian Legal Lexpert Directory—Corporate Finance and Securities
The Best Lawyers in Canada—Mergers and Acquisitions Law; Securities Law
Bar Admissions
Québec, 2003
Education
Harvard Law School, Executive Education: Accelerated Leadership Program, 2016
McGill University, BCL/LLB (with Great Distinction), 2002
McGill University, BA Philosophy (with Distinction), 1999
Board Memberships
The Canadian Club of Montréal, director
BELLUS Health Inc., corporate secretary
Fondation de la Maison Théâtre, chairman
